Elevance Health Inc. (ELV) Tops Q1 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ELV Hot Sheet
Join SI Premium – FREE
Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $9.46, $0.15 better than the analyst estimate of $9.31. Revenue for the quarter came in at $41.9 billion versus the consensus estimate of $40.92 billion.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Viper Energy (VNOM) Tops Q3 EPS by 3c
- Philips (PHG) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
